| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5693953 | European Urology | 2017 | 8 Pages |
Abstract
Collection of circulating tumor DNA is feasible in patients with metastatic renal cell carcinoma, and analysis of a large cohort demonstrates significant changes in circulating tumor DNA profile across patients' clinical course which may have therapeutic implications.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Sumanta K. Pal, Guru Sonpavde, Neeraj Agarwal, Nicholas J. Vogelzang, Sandy Srinivas, Naomi B. Haas, Sabina Signoretti, Bradley A. McGregor, Jeremy Jones, Richard B. Lanman, Kimberly C. Banks, Toni K. Choueiri,